Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17720360
[patent_doc_number] => 20220213080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => PIPERLONGUMINE-BASED COMPOUND AND IMMUNO REGULATOR COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/525116
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 320
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525116 | Piperlongumine-based compound and immuno regulator comprising the same | Nov 11, 2021 | Issued |
Array
(
[id] => 18575491
[patent_doc_number] => 11732005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Peptidomimetic proteasome inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/521328
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20716
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 457
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521328
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/521328 | Peptidomimetic proteasome inhibitors | Nov 7, 2021 | Issued |
Array
(
[id] => 18518460
[patent_doc_number] => 11708340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Benzothia(di)azepine compounds and their use as bile acid modulators
[patent_app_type] => utility
[patent_app_number] => 17/508852
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 44060
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17508852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/508852 | Benzothia(di)azepine compounds and their use as bile acid modulators | Oct 21, 2021 | Issued |
Array
(
[id] => 18643272
[patent_doc_number] => 11767332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Glucose-sensitive albumin-binding derivatives
[patent_app_type] => utility
[patent_app_number] => 17/500242
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 43912
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 522
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500242 | Glucose-sensitive albumin-binding derivatives | Oct 12, 2021 | Issued |
Array
(
[id] => 17761412
[patent_doc_number] => 20220235024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => ACYLOXY SUBSTITUTED PHENYL DITHIANE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/499684
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499684 | Acyloxy substituted phenyl dithiane derivatives | Oct 11, 2021 | Issued |
Array
(
[id] => 17627405
[patent_doc_number] => 20220162420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => ZINC OXIDE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/489321
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489321
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489321 | Zinc oxide complexes | Sep 28, 2021 | Issued |
Array
(
[id] => 18575464
[patent_doc_number] => 11731977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => SGC stimulators
[patent_app_type] => utility
[patent_app_number] => 17/485892
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 48929
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 886
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485892
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/485892 | SGC stimulators | Sep 26, 2021 | Issued |
Array
(
[id] => 19105758
[patent_doc_number] => 11958839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Bicyclic CX3CR1 receptor agonists
[patent_app_type] => utility
[patent_app_number] => 17/481653
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28870
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 270
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/481653 | Bicyclic CX3CR1 receptor agonists | Sep 21, 2021 | Issued |
Array
(
[id] => 18545242
[patent_doc_number] => 11718581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Alkoxylated secondary alcohol sulfates
[patent_app_type] => utility
[patent_app_number] => 17/471992
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3343
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471992
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471992 | Alkoxylated secondary alcohol sulfates | Sep 9, 2021 | Issued |
Array
(
[id] => 17312729
[patent_doc_number] => 20210401777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA
[patent_app_type] => utility
[patent_app_number] => 17/471892
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471892
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471892 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | Sep 9, 2021 | Abandoned |
Array
(
[id] => 18225628
[patent_doc_number] => 20230064622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => PROCESS FOR RECOVERING PROPYLENE OXIDE AND CARBON DIOXIDE IN PPC POLYOL PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/460462
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460462 | Process for recovering propylene oxide and carbon dioxide in PPC polyol production | Aug 29, 2021 | Issued |
Array
(
[id] => 18620390
[patent_doc_number] => 11753418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Compounds for the modulation of Myc activity
[patent_app_type] => utility
[patent_app_number] => 17/411965
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40751
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 620
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/411965 | Compounds for the modulation of Myc activity | Aug 24, 2021 | Issued |
Array
(
[id] => 17578691
[patent_doc_number] => 20220135546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/401833
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401833 | Compounds, compositions, and methods | Aug 12, 2021 | Issued |
Array
(
[id] => 17443652
[patent_doc_number] => 20220064157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => NOVEL HIGH PENETRATION DRUGS AND THEIR COMPOSITIONS THEREOF FOR TREATMENT OF PARKINSON DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/396975
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396975
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396975 | High penetration drugs and their compositions thereof for treatment of Parkinson diseases | Aug 8, 2021 | Issued |
Array
(
[id] => 18701276
[patent_doc_number] => 11787775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Therapeutic compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/383422
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59549
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383422 | Therapeutic compounds and methods of use | Jul 21, 2021 | Issued |
Array
(
[id] => 18460351
[patent_doc_number] => 11684629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
[patent_app_type] => utility
[patent_app_number] => 17/378248
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 28015
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 538
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378248
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378248 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives | Jul 15, 2021 | Issued |
Array
(
[id] => 17399540
[patent_doc_number] => 20220041630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => PROCESSES FOR THE PREPARATION OF ARGINASE INHIBITORS AND THEIR SYNTHETIC INTERMEDIATES
[patent_app_type] => utility
[patent_app_number] => 17/305932
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305932 | PROCESSES FOR THE PREPARATION OF ARGINASE INHIBITORS AND THEIR SYNTHETIC INTERMEDIATES | Jul 15, 2021 | Abandoned |
Array
(
[id] => 18211701
[patent_doc_number] => 20230057964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => METHOD FOR PREPARING ACRYLONITRILE DIMER
[patent_app_type] => utility
[patent_app_number] => 17/790442
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790442 | Method for preparing acrylonitrile dimer | Jul 6, 2021 | Issued |
Array
(
[id] => 18179117
[patent_doc_number] => 20230039846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/368708
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368708 | COMPOUNDS AND METHODS OF USE | Jul 5, 2021 | Abandoned |
Array
(
[id] => 18353952
[patent_doc_number] => 11642336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => 5-HT
[patent_app_type] => utility
[patent_app_number] => 17/368351
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 44889
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 308
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368351 | 5-HT | Jul 5, 2021 | Issued |